IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MOTTA, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.794
AS - Asia 7.009
NA - Nord America 6.940
SA - Sud America 707
AF - Africa 157
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.696
GB - Regno Unito 4.027
CN - Cina 2.283
SG - Singapore 2.047
DE - Germania 1.286
IT - Italia 1.048
SE - Svezia 885
RU - Federazione Russa 777
HK - Hong Kong 552
BR - Brasile 493
VN - Vietnam 429
TR - Turchia 388
NL - Olanda 359
FR - Francia 354
UA - Ucraina 352
BD - Bangladesh 340
KR - Corea 295
IN - India 276
IE - Irlanda 231
FI - Finlandia 178
EU - Europa 173
CA - Canada 158
CO - Colombia 86
GR - Grecia 76
JP - Giappone 71
PH - Filippine 69
ID - Indonesia 67
CI - Costa d'Avorio 56
AR - Argentina 41
PL - Polonia 38
MX - Messico 37
IQ - Iraq 32
BE - Belgio 28
DK - Danimarca 28
ES - Italia 20
TW - Taiwan 20
ZA - Sudafrica 20
SA - Arabia Saudita 18
MA - Marocco 17
PK - Pakistan 17
AU - Australia 16
EC - Ecuador 16
PT - Portogallo 16
CL - Cile 15
IL - Israele 14
PY - Paraguay 14
AT - Austria 13
CH - Svizzera 13
MY - Malesia 12
RO - Romania 12
VE - Venezuela 12
EG - Egitto 11
JO - Giordania 11
PE - Perù 11
KE - Kenya 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 8
NP - Nepal 8
TN - Tunisia 8
UZ - Uzbekistan 8
ET - Etiopia 7
JM - Giamaica 7
BO - Bolivia 6
LU - Lussemburgo 6
NG - Nigeria 6
NO - Norvegia 6
TH - Thailandia 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
HU - Ungheria 4
KW - Kuwait 4
PA - Panama 4
BZ - Belize 3
CW - ???statistics.table.value.countryCode.CW??? 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
CG - Congo 2
EE - Estonia 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
LC - Santa Lucia 2
LT - Lituania 2
LV - Lettonia 2
ME - Montenegro 2
Totale 24.760
Salva come PNG Salva come JPEG
Città #
Southend 3.754
Singapore 1.083
Ashburn 577
Hong Kong 534
Chandler 510
Seattle 481
Beijing 454
San Jose 421
Milan 403
Hanover 345
Princeton 320
Jacksonville 268
Dallas 263
Wilmington 262
Council Bluffs 255
Dublin 231
Redmond 214
New York 173
Los Angeles 165
Nanjing 162
Frankfurt am Main 159
Ann Arbor 142
Santa Clara 141
Sakarya 132
Mountain View 130
Lauterbourg 124
Dearborn 121
Bengaluru 119
Fairfield 119
Moscow 112
Toronto 111
Ho Chi Minh City 110
Woodbridge 108
Des Moines 106
Boardman 105
Buffalo 97
Andover 92
Shanghai 91
Grafing 87
Hanoi 87
Shenyang 82
Guangzhou 81
Jinan 78
Munich 78
Serra 78
Bogotá 76
Houston 71
Somerville 56
Abidjan 55
Cangzhou 54
Tianjin 54
Athens 53
Hefei 50
Redwood City 48
Tokyo 48
São Paulo 45
Changsha 44
Dong Ket 44
Zhengzhou 44
Cambridge 42
Nanchang 41
Columbus 40
Bitonto 39
The Dalles 38
Hangzhou 36
Hebei 35
Norwalk 34
Jakarta 33
Rome 33
Kiez 30
Jiaxing 28
Fuzhou 27
San Diego 27
Helsinki 26
Mannheim 26
Medford 26
Shenzhen 26
Seoul 24
Auburn Hills 23
Ningbo 23
Atlanta 22
Brussels 22
Sunnyvale 22
Berlin 21
Lanzhou 21
Taizhou 21
Phoenix 20
Wuhan 20
Roxbury 19
Istanbul 17
Porto Alegre 17
Turin 17
Warsaw 17
Chicago 16
Da Nang 16
Haikou 16
Naples 15
Nürnberg 15
Eitensheim 14
Haiphong 14
Totale 15.326
Salva come PNG Salva come JPEG
Nome #
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 438
Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer cells 377
The Androgen Derivative 5alpha-Androstan-3beta,17beta-diol Inhibits Prostate Cancer Cell Migration throught Activation of Estrogen Receptor beta subtype 336
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion 316
In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth : hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells 311
Smad proteins are targets of transforming growth factor beta1 in immortalised gonadotrophin-releasing hormone releasing neurones 294
Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells 273
Altered peripheral myelination in mice lacking GABAB receptors 267
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 265
Free and bound leptin in prepubertal children with Down's syndrome and different degrees of adiposity 264
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alpha v beta 3 integrin and PI3-K/Akt signaling 260
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 255
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells : Crucial role of 5-lipoxygenase 252
EFFECTS OF SOMATOSTATIN ANALOGS ON CELL PROLIFERATION OF HUMAN ANDROGEN-INDEPENDENT PROSTATE CANCER CELL LINES 252
"Ultrashort" control of hypothalamic hormones secretion : a brief history 248
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells 246
Aldosterone receptor antagonists: biology and novel therapeutical applications 243
The Androgen Derivative 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) Inhibits Prostate Cancer Cell Migration through Activation of the Estrogen Receptor beta. 242
Role of the energy sensor AMP-activated protein kinase in the regulation of immature GnRH neuron migration 237
Sexual differentiation of the brain: role of testosterone and its active metabolites 236
Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastorna cells 236
The synthesis of glycoprotein Po and peripheral myelin protein 22 in sciatic nerve of male rats is modulated by testosterone metabolites 235
Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation : studies on the possible mechanism of action in DU145 cells 235
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) 232
Aldosterone receptor antagonists: biology and novel therapeutic applications 228
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines 225
Fisiologia endocrina : principi generali 219
Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression 218
Expression of functional ciliary neurotrophic factor receptors in immortalized gonadotrophin-releasing hormone-secreting neurones 218
Leukemia inhibitory factor induces the chemomigration of immortalized gonadotropin-releasing hormone neurons through the independent activation of the Janus kinase/signal transducer and activator of transcription 3, mitogen-activated protein kinase/extracellularly regulated kinase 1/2, and phosphatidylinositol 3-kinase/Akt signaling pathways 217
Aging and the hypothalamic-pituitary complex of the male rat 210
GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies 209
GABA receptors in the peripheral nervous system: A new aspect of the axon-Schwann cell interaction 204
Is ghrelin a potential signal of decreased fat-free mass in elderly subjects? 202
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines 200
Aging and the hypothalamo-pituitary-testicular axis in the rat 199
Presence of 5α-Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue 198
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference 195
Profilo di espressione genica dei recettori per somatostatina e dopamina in adenomi ipofisari clinicamente non funzionanti 195
Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons 194
GABAergic control of peripheral nervous system : new insights from the GABA-B(1)(-/-) knockout mice 193
Regulation of prostate cancer cell proliferation by somatostatin receptor activation 193
Leukemia inhibitory factor promotes the chemomigration of immature GnRH neurons 191
Endocrinology of aging 190
Hypothalamic neuropeptide systems as targets for potential anti-obesity drugs 189
Role of glucocorticoids in the migration of immature LHRH neurons 189
Schwann-like adult stem cells derived from bone marrow and adipose tissue express γ-aminobutyric acid type B receptors 189
Relevance of the neuropeptide Y system in the biology of cancer progression 188
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion 185
Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation 185
Role of Estrogen Receptor beta on prostate cancer cell migration 184
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 183
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 183
Androgen metabolism in different target tissues 182
Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer 180
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 180
The 5alpha-reductase in the central nervous system: expression and modes of control 180
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 179
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 179
Total, free and bound leptin and thyroid function in elderly women with different body weights 178
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors 178
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer 176
Neuropeptide Y-Y1 receptors mediate the effects of Neuropeptide Y on prostate cancer cell growth 175
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor 174
Tamoxifen does not block the inhibitory effect of testosterone on FSH release in rats 174
Effect of 5 alpha-reduced androgens on prolactin secretion 174
Regolazione del sistema attivatore del plasminogeno da parte degli ormoni glucocorticoidi nella progressione metastatica del cancro prostatico 173
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 173
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines 171
Insulin-like Growth Factor-1 profiling in Amyotrophic Lateral Sclerosis (ALS) 170
Antitumor effects of carnertinib in castration resistant prostate cancer models : a comparative study with erlotinib 170
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 170
Human prostatic-carcinoma cell-line LNCaP degrades luteinizing-hormone-releasing hormone 170
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 168
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system 168
Somatostatin receptor regulation and effects of somatostatin and somatostatin analogues on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP 166
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 165
TESTOSTERONE METABOLITES DO NOT PARTICIPATE IN THE CONTROL OF HYPOTHALAMIC LH-RELEASING HORMONE 165
Gonadotropin-Releasing Hormone (GnRH) receptors in tumors : a new rationale for the therapeutical application of GnRH analogs in cancer patients? 164
Leptin: a possible link between food intake, energy expenditure, and reproductive function 163
Neuroactive steroids and GABA receptors-mediated effects in Peripheral nervous system 162
Metabotropic GABA-B receptor and pain : new insights from GABA-B1 knock-out mice 162
Glutamic acid decarboxylase (GAD) isoform of 67 kDa regulates the synthesis of GABA in Schwann cells 161
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3 161
In vivo growth properties and molecular marker expression of DU145 human prostate tumor cells expressing recombinant androgen receptor 160
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer 159
Somatostatin and dopamine receptor dimerization in prostate and lung tumor cell lines 159
Type 1 astrocytes influence luteinizing hormone-releasing hormone release from the hypothalamic cell line GT1-1: is transforming growth factor-beta the principle involved? 158
Effects of 6- and 7-hydroxy metabolites of 3β,17β-dihydroxy-5α-androstane on gonadotrophin and prolactin secretion and on sex accessories weight of male rats 158
Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells 157
Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145 154
Il sistema riproduttivo 152
Effect of neurotensin on glucose and insulin portal blood levels in hyperglycemic rats 152
Expression/function of receptors for Ciliary Neurotrophic Factor in mature and immature mouse gonadotropin-releasing hormone (GNRH)-secreting neurons 150
Testosterone and the control of hypothalamic GnRH 150
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 149
Effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano 148
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 148
Somatostatin and dopamine receptor regulation and effects of a new somatostatin/dopamine chimeric compound on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP 148
Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism 147
Totale 20.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 0 0 242
2021/20222.055 164 29 162 151 174 123 151 120 264 152 278 287
2022/20231.847 254 134 132 258 219 376 50 167 145 13 79 20
2023/20241.156 33 113 59 92 308 56 25 74 14 40 156 186
2024/20252.948 111 215 37 277 225 109 144 370 134 339 228 759
2025/20266.331 600 334 673 453 667 399 642 357 775 630 696 105
Totale 26.065